Literature DB >> 31792010

Exogenous Alginate Protects Staphylococcus aureus from Killing by Pseudomonas aeruginosa.

Courtney E Price1, Dustin G Brown2, Dominique H Limoli3, Vanessa V Phelan2, George A O'Toole4.   

Abstract

Cystic fibrosis (CF) patients chronically infected with both Pseudomonas aeruginosa and Staphylococcus aureus have worse health outcomes than patients who are monoinfected with either P. aeruginosa or S. aureus We showed previously that mucoid strains of P. aeruginosa can coexist with S. aureus in vitro due to the transcriptional downregulation of several toxic exoproducts typically produced by P. aeruginosa, including siderophores, rhamnolipids, and HQNO (2-heptyl-4-hydroxyquinoline N-oxide). Here, we demonstrate that exogenous alginate protects S. aureus from P. aeruginosa in both planktonic and biofilm coculture models under a variety of nutritional conditions. S. aureus protection in the presence of exogenous alginate is due to the transcriptional downregulation of pvdA, a gene required for the production of the iron-scavenging siderophore pyoverdine as well as the downregulation of the PQS (Pseudomonas quinolone signal) (2-heptyl-3,4-dihydroxyquinoline) quorum sensing system. The impact of exogenous alginate is independent of endogenous alginate production. We further demonstrate that coculture of mucoid P. aeruginosa with nonmucoid P. aeruginosa strains can mitigate the killing of S. aureus by the nonmucoid strain of P. aeruginosa, indicating that the mechanism that we describe here may function in vivo in the context of mixed infections. Finally, we investigated a panel of mucoid clinical isolates that retain the ability to kill S. aureus at late time points and show that each strain has a unique expression profile, indicating that mucoid isolates can overcome the S. aureus-protective effects of mucoidy in a strain-specific manner.IMPORTANCE CF patients are chronically infected by polymicrobial communities. The two dominant bacterial pathogens that infect the lungs of CF patients are P. aeruginosa and S. aureus, with ∼30% of patients coinfected by both species. Such coinfected individuals have worse outcomes than monoinfected patients, and both species persist within the same physical space. A variety of host and environmental factors have been demonstrated to promote P. aeruginosa-S. aureus coexistence, despite evidence that P. aeruginosa kills S. aureus when these organisms are cocultured in vitro Thus, a better understanding of P. aeruginosa-S. aureus interactions, particularly mechanisms by which these microorganisms are able to coexist in proximal physical space, will lead to better-informed treatments for chronic polymicrobial infections.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  HQNO; Nanostring; PQS; Pseudomonas aeruginosa; Staphylococcus aureus; alginate; cystic fibrosis; mucoid; polymicrobial; pyochelin; pyoverdine; siderophores

Year:  2020        PMID: 31792010      PMCID: PMC7099135          DOI: 10.1128/JB.00559-19

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  55 in total

1.  Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model.

Authors:  Stephanie DeLeon; Allie Clinton; Haley Fowler; Jake Everett; Alexander R Horswill; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 2.  Cystic fibrosis: a polymicrobial infectious disease.

Authors:  Christopher D Sibley; Harvey Rabin; Michael G Surette
Journal:  Future Microbiol       Date:  2006-06       Impact factor: 3.165

3.  Use of a Multiplex Transcript Method for Analysis of Pseudomonas aeruginosa Gene Expression Profiles in the Cystic Fibrosis Lung.

Authors:  Alex H Gifford; Sven D Willger; Emily L Dolben; Lisa A Moulton; Dana B Dorman; Heather Bean; Jane E Hill; Thomas H Hampton; Alix Ashare; Deborah A Hogan
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

4.  Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.

Authors:  Don B Sanders; Rachel C L Bittner; Margaret Rosenfeld; Lucas R Hoffman; Gregory J Redding; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

5.  Control of AlgU, a member of the sigma E-like family of stress sigma factors, by the negative regulators MucA and MucB and Pseudomonas aeruginosa conversion to mucoidy in cystic fibrosis.

Authors:  M J Schurr; H Yu; J M Martinez-Salazar; J C Boucher; V Deretic
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

6.  Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  Alessandra Bragonzi; Lutz Wiehlmann; Jens Klockgether; Nina Cramer; Dieter Worlitzsch; Gerd Döring; Burkhard Tümmler
Journal:  Microbiology       Date:  2006-11       Impact factor: 2.777

7.  Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770.

Authors:  Fredrick Van Goor; Sabine Hadida; Peter D J Grootenhuis; Bill Burton; Dong Cao; Tim Neuberger; Amanda Turnbull; Ashvani Singh; John Joubran; Anna Hazlewood; Jinglan Zhou; Jason McCartney; Vijayalaksmi Arumugam; Caroline Decker; Jennifer Yang; Chris Young; Eric R Olson; Jeffery J Wine; Raymond A Frizzell; Melissa Ashlock; Paul Negulescu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-21       Impact factor: 11.205

8.  Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.

Authors:  D W Martin; M J Schurr; M H Mudd; J R Govan; B W Holloway; V Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

9.  Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.

Authors:  Deborah A Hogan; Sven D Willger; Emily L Dolben; Thomas H Hampton; Bruce A Stanton; Hilary G Morrison; Mitchell L Sogin; Julianna Czum; Alix Ashare
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

10.  Pseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection.

Authors:  Giulia Orazi; George A O'Toole
Journal:  MBio       Date:  2017-07-18       Impact factor: 7.867

View more
  11 in total

Review 1.  Antibacterial contact-dependent proteins secreted by Gram-negative cystic fibrosis respiratory pathogens.

Authors:  Cristian V Crisan; Joanna B Goldberg
Journal:  Trends Microbiol       Date:  2022-04-26       Impact factor: 18.230

2.  Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Laura Camus; Paul Briaud; François Vandenesch; Anne Doléans-Jordheim; Karen Moreau
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Interbacterial Antagonism Mediated by a Released Polysaccharide.

Authors:  Yiwei Liu; Erin S Gloag; Preston J Hill; Matthew R Parsek; Daniel J Wozniak
Journal:  J Bacteriol       Date:  2022-04-21       Impact factor: 3.476

4.  Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus?

Authors:  Michael J Schurr
Journal:  J Bacteriol       Date:  2020-03-26       Impact factor: 3.490

5.  Mucoid Pseudomonas aeruginosa Can Produce Calcium-Gelled Biofilms Independent of the Matrix Components Psl and CdrA.

Authors:  Holly M Jacobs; Lindsey O'Neal; Edward Lopatto; Daniel J Wozniak; Thomas Bjarnsholt; Matthew R Parsek
Journal:  J Bacteriol       Date:  2022-04-13       Impact factor: 3.476

Review 6.  Molecular Mechanisms of Staphylococcus and Pseudomonas Interactions in Cystic Fibrosis.

Authors:  Lalitha Biswas; Friedrich Götz
Journal:  Front Cell Infect Microbiol       Date:  2022-01-06       Impact factor: 5.293

7.  A Relevant Wound-Like in vitro Media to Study Bacterial Cooperation and Biofilm in Chronic Wounds.

Authors:  Cassandra Pouget; Catherine Dunyach-Remy; Thierry Bernardi; Christian Provot; Jason Tasse; Albert Sotto; Jean-Philippe Lavigne
Journal:  Front Microbiol       Date:  2022-04-06       Impact factor: 6.064

Review 8.  Bacterial Interactions in the Context of Chronic Wound Biofilm: A Review.

Authors:  Benjamin A R N Durand; Cassandra Pouget; Chloé Magnan; Virginie Molle; Jean-Philippe Lavigne; Catherine Dunyach-Remy
Journal:  Microorganisms       Date:  2022-07-25

Review 9.  An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence.

Authors:  Charles D Morin; Eric Déziel; Jeff Gauthier; Roger C Levesque; Gee W Lau
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

10.  Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.

Authors:  Marie K Wieneke; Felix Dach; Claudia Neumann; Dennis Görlich; Lena Kaese; Theo Thißen; Angelika Dübbers; Christina Kessler; Jörg Große-Onnebrink; Peter Küster; Holger Schültingkemper; Bianca Schwartbeck; Johannes Roth; Jerzy-Roch Nofer; Janina Treffon; Julia Posdorfer; Josefine Marie Boecken; Mariele Strake; Miriam Abdo; Sophia Westhues; Barbara C Kahl
Journal:  mSphere       Date:  2021-06-23       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.